120P Survival outcomes of metastatic breast cancer who have been treated with bevacizumab and eribulin in the real world. - BEV + PTX followed by eribulin versus the reverse sequence
Year: 2016
Type: article
Study design: Observational Study
Source: Annals of Oncology
Authors: K. Matsui, M. Earashi, T. Nagata, A. Yoshikawa, W. Fukushima, Z. Nozaki, Y. Tanada, K. Oyama, K. Shimada, K. Kiyohara, T. Shimizu, K. Iwata, T. Yoshida, T. Ii, K. Maeda
Institutions: Toyama Prefectural Central Hospital, Toyama University Hospital, University of Toyama, Toyama City Hospital, Takaoka City Hospital, Toyama Red Cross Hospital, Kouseiren Takaoka Hospital, Tonami General Hospital, Saiseikai Toyama Hospital, Kurobe City Hospital, Saiseikai Takaoka Hospital
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2587445083